Assuntos
Terapia de Ressincronização Cardíaca/métodos , Cardiomiopatia Dilatada , Fármacos Cardiovasculares/uso terapêutico , Insuficiência Cardíaca , Cardiomiopatia Dilatada/complicações , Cardiomiopatia Dilatada/diagnóstico , Progressão da Doença , Ecocardiografia/métodos , Eletrocardiografia/métodos , Feminino , Gadolínio , Insuficiência Cardíaca/diagnóstico , Insuficiência Cardíaca/etiologia , Insuficiência Cardíaca/fisiopatologia , Insuficiência Cardíaca/terapia , Humanos , Imageamento por Ressonância Magnética/métodos , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Resultado do TratamentoRESUMO
Based on the 2010-2012 data from the National Registry of Myocardial Infarction, the authors analyzed the scope and pattern of emergency medical care for patients with ST-segment elevation acute coronary syndrome (ACS). The proportion of patients undergoing emergency endovascular interventions of the total number of those with ST-segment elevation ACS was 22.3% in 2010, 22.1% in 2011, and 28.5% in 2012. Thrombolytic therapy rates were 27.6% in 2010, 30.2% in 2011, and 30.3% in 2012. The percentage of patients who did not receive any reperfusion was 50, 46, and 42% in 2010, 2011, and 2012, respectively. At the same time, the proportion of patients who were admitted to hospital within 12 hours after a pain attack, but received no revascularization was 25.7% in 2010, 19.3% in 2011, and 16.9% in 2012. Hospital deaths due to ST-segment ACS were 7.7, and 7.0, and 6.8% in 2010, 2011, and 2012, respectively. The reduction in hospital mortality rates of myocardial infarction was due to both the wide introduction of high technology care and the increased therapeutic window of the most available reperfusion method, such as thrombolytic therapy.
